SCHEMBL6167912

SCHEMBL6167912

Cc1onc(-c2ccc(S(=O)(=O)C(C)[Si](C)(C)C)cc2)c1-c1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 17/20 0.68
PTGS1 P23219 8/20 0.68
MT-CO2 P00403 3/20 0.68
CA12 O43570 1/20 0.68
CA1 P00915 1/20 0.68
CA2 P00918 1/20 0.68
LMNA P02545 1/20 0.68
CA3 P07451 1/20 0.68
ADRB2 P07550 1/20 0.68
ADRB1 P08588 1/20 0.68
CYP3A4 P08684 1/20 0.68
ADORA3 P0DMS8 1/20 0.68
CHRM1 P11229 1/20 0.68
ADRA2B P18089 1/20 0.68
CA4 P22748 1/20 0.68
CA6 P23280 1/20 0.68
SLC6A2 P23975 1/20 0.68
PDE4A P27815 1/20 0.68
ADORA1 P30542 1/20 0.68
CA5A P35218 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5422595 0.85 PTGS2 (0.77) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL8802159 0.84 PTGS2 (0.64) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL28961699 0.84 PTGS2 (0.79) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL14267653 0.82 PTGS2 (0.77) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL5703656 0.82 PTGS2 (0.77) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL6168344 0.81 PTGS2 (1.00) PTGS2PTGS1MT-CO2CA12CA1
Valdecoxib SCHEMBL3356 0.81 PTGS2 (1.00) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL6262268 0.81 PTGS2 (0.75) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL6013897 0.81 PTGS2 (0.76) PTGS2PTGS1MT-CO2CA12CA1
Valdecoxib SCHEMBL3853130 0.81 PTGS2 (1.00) PTGS2PTGS1MT-CO2CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 EP disclosed
EP-0809636-B1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-09-04 EP disclosed
EP-1223167-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle & Co. (US) 2002-07-17 EP disclosed
US-5859257-A ANTIINFLAMMATORY, ANTIARTHRITIC AGENTS G. D. SEARLE & CO. (US) 1999-01-12 US disclosed